VistaGen Reports Top Line Results from NIMH's Exploratory Study of AV-101 Monotherapy for Treatment-Resistant Depression - Yahoo Finance

Submitted by Anonymous (not verified) on Thu, 05/02/2019 - 11:00

VistaGen Reports Top Line Results from NIMH's Exploratory Study of AV-101 Monotherapy for Treatment-Resistant Depression  Yahoo FinanceSOUTH SAN FRANCISCO, CA / ACCESSWIRE / May 2, 2019 / VistaGen Therapeutics (VTGN), a clinical-stage biopharmaceutical company developing new ...